These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37681059)

  • 21. Cardiac Power Output Is Independently and Incrementally Associated With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction.
    Harada T; Yamaguchi M; Omote K; Iwano H; Mizuguchi Y; Amanai S; Yoshida K; Kato T; Kurosawa K; Nagai T; Negishi K; Anzai T; Obokata M
    Circ Cardiovasc Imaging; 2022 Feb; 15(2):e013495. PubMed ID: 35144484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An autopsy case of Parkes-Weber syndrome with high-output heart failure: Hemodynamic alterations following treatment for arteriovenous fistulas.
    Yamamoto H; Makiuchi M; Itamoto C; Hata H
    J Cardiol Cases; 2022 Aug; 26(2):118-121. PubMed ID: 35949574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril treatment does not restore either the renal or the ANF release response during volume expansion in moderate to severe high output heart failure.
    Garcia R; Bonhomme MC; Diebold S
    Cardiovasc Res; 1994 Oct; 28(10):1533-9. PubMed ID: 8001042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biatrial Electrical and Structural Atrial Changes in Heart Failure: Electroanatomic Mapping in Persistent Atrial Fibrillation in Humans.
    Prabhu S; Voskoboinik A; McLellan AJA; Peck KY; Pathik B; Nalliah CJ; Wong GR; Azzopardi SM; Lee G; Mariani J; Ling LH; Taylor AJ; Kalman JM; Kistler PM
    JACC Clin Electrophysiol; 2018 Jan; 4(1):87-96. PubMed ID: 29600790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic Heart Failure With Preserved Systolic Function and Reversible Dilatation of Cardiac Chambers].
    Blagova OV; Volkov SV; Nedostup AV; Korobkov AO; Mostovoy IV; Sergushina NG; Gagarina NV; Mershina EA
    Kardiologiia; 2016 Jun; 56(6):102-108. PubMed ID: 28290856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial.
    Solomon SD; Vaduganathan M; Claggett BL; de Boer RA; DeMets D; Hernandez AF; Inzucchi SE; Kosiborod MN; Lam CSP; Martinez F; Shah SJ; Belohlavek J; Chiang CE; Willem Borleffs CJ; Comin-Colet J; Dobreanu D; Drozdz J; Fang JC; Alcocer Gamba MA; Al Habeeb W; Han Y; Cabrera Honorio JW; Janssens SP; Katova T; Kitakaze M; Merkely B; O'Meara E; Kerr Saraiva JF; Tereschenko SN; Thierer J; Vardeny O; Verma S; Vinh PN; Wilderäng U; Zaozerska N; Lindholm D; Petersson M; McMurray JJV
    JACC Heart Fail; 2022 Mar; 10(3):184-197. PubMed ID: 35241246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate Versus Rhythm Control in Heart Failure Patients with Post-Operative Atrial Fibrillation After Cardiac Surgery.
    Yang E; Spragg D; Schulman S; Gilotra NA; Kilic A; Salenger R; Whitman G; Metkus TS
    J Card Fail; 2021 Aug; 27(8):915-919. PubMed ID: 34364670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter ablation of malignant atrial fibrillation as palliative therapy for end-stage heart failure: A case report.
    Okada M; Tanaka N; Tanaka K; Hirao Y; Inoue K
    J Cardiol Cases; 2023 Sep; 28(3):95-99. PubMed ID: 37671262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis.
    Malik J; Valerianova A; Pesickova SS; Michalickova K; Hladinova Z; Hruskova Z; Bednarova V; Rocinova K; Tothova M; Kratochvilova M; Kaiserova L; Buryskova Salajova K; Lejsek V; Sevcik M; Tesar V
    Front Cardiovasc Med; 2023; 10():1130618. PubMed ID: 37324637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
    Martens P; Dauw J; Verbrugge FH; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Circulation; 2023 Jan; 147(3):201-211. PubMed ID: 36335479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum.
    Moysidis DV; Kartas A; Samaras A; Papazoglou AS; Akrivos E; Vouloagkas I; Papanastasiou A; Vrana E; Baroutidou A; Botis M; Liampas E; Tsagkaris C; Karagiannidis E; Karvounis H; Tzikas A; Giannakoulas G
    Hellenic J Cardiol; 2022; 66():32-40. PubMed ID: 35278695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction.
    Patel RB; Reddy VY; Komtebedde J; Wegerich SW; Sekaric J; Swarup V; Walton A; Laurent G; Chetcuti S; Rademann M; Bergmann M; McKenzie S; Bugger H; Bruno RR; Herrmann HC; Nair A; Gupta DK; Lim S; Kapadia S; Gordon R; Vanderheyden M; Noel T; Bailey S; Gertz ZM; Trochu JN; Cutlip DE; Leon MB; Solomon SD; van Veldhuisen DJ; Auricchio A; Shah SJ
    JACC Heart Fail; 2023 Oct; 11(10):1351-1362. PubMed ID: 37480877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A covert complication of arteriovenous fistulas.
    Imran TF; Hashim H; Beidas AK; Oriscello R
    J Cardiol Cases; 2015 May; 11(5):132-135. PubMed ID: 30546550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial.
    Lund LH; Savarese G; Venkateshvaran A; Benson L; Lundberg A; Donal E; Daubert JC; Oger E; Linde C; Hage C
    ESC Heart Fail; 2022 Feb; 9(1):164-177. PubMed ID: 34811954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
    Al-Jazairi MIH; Nguyen BO; De With RR; Smit MD; Weijs B; Hobbelt AH; Alings M; Tijssen JGP; Geelhoed B; Hillege HL; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Blaauw Y; Rienstra M;
    Europace; 2021 Sep; 23(9):1359-1368. PubMed ID: 33899093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac failure and pulmonary hypertension secondary to renal arteriovenous malformation: a case report.
    Albak LJ; Shah AH; Tam JW
    J Med Case Rep; 2021 Mar; 15(1):177. PubMed ID: 33785059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.
    Pellicori P; Zhang J; Lukaschuk E; Joseph AC; Bourantas CV; Loh H; Bragadeesh T; Clark AL; Cleland JG
    Eur Heart J; 2015 Mar; 36(12):733-42. PubMed ID: 25336215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.